Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02913404 · ClinicalTrials.gov registry record · NA

ACL-reconstruction vs ACL-reconstruction With EAT

A NA study of ACL, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02913404 is a NA study of ACL that has completed, run by University of Pittsburgh. The registered enrollment target is 20 participants, below the 100-participant average among 6 other ACL trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02913404, a NA study of ACL, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to asses functional biomechanical outcomes and patient reported outcome measures following single bundle ACL reconstruction (ACL-R) compared to single bundle ACL reconstruction and extra articular tenodesis (ACL-R+EAT).

Conditions Studied

Interventions

  • PROCEDURE ACL Reconstruction
  • PROCEDURE ACL Recon. extra-articular-tenodesis

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Biodynamics Lab - Pittsburgh

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-01
Est. Completion 2020-09
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02913404

The ClinicalTrials.gov registry entry for NCT02913404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 6 other ACL trials with a reported enrollment target (80% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ACL appearing as the primary indexed condition, and to 2 interventions - of which ACL Reconstruction is the first listed.

NCT02913404 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02913404 about?

NCT02913404 is a clinical study titled "ACL-reconstruction vs ACL-reconstruction With EAT". The purpose of this study is to asses functional biomechanical outcomes and patient reported outcome measures following single bundle ACL reconstruction (ACL-R) compared to single bundle ACL reconstruction and extra articular tenodesis (ACL-R+EAT).

What is the current status of trial NCT02913404?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-01. Estimated completion is 2020-09.

What conditions does trial NCT02913404 study?

This clinical trial studies the following conditions: ACL.

What interventions are being tested in trial NCT02913404?

The interventions under investigation include: ACL Reconstruction (PROCEDURE), ACL Recon. extra-articular-tenodesis (PROCEDURE).

Who is sponsoring clinical trial NCT02913404?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02913404 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ACL

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.